| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rapid Therapeutic Science Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.005 |
| 52 Week High | US$0.16 |
| 52 Week Low | US$0.0005 |
| Beta | -10.93 |
| 1 Month Change | 47.06% |
| 3 Month Change | 47.06% |
| 1 Year Change | -96.15% |
| 3 Year Change | -99.95% |
| 5 Year Change | n/a |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| RTSL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -3.7% |
| 1Y | -96.2% | -2.2% | 20.5% |
Return vs Industry: RTSL underperformed the US Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: RTSL underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| RTSL volatility | |
|---|---|
| RTSL Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RTSL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine RTSL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 4 | Don Schmidt | www.rtslco.com |
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.
Rapid Therapeutic Science Laboratories, Inc. Fundamentals Summary
| RTSL fundamental statistics | |
|---|---|
| Market cap | US$94.93k |
| Earnings (TTM) | US$59.56k |
| Revenue (TTM) | n/a |
1.6x
P/E Ratio0.0x
P/S RatioIs RTSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RTSL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$59.56k |
| Earnings | US$59.56k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0031 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -125.9% |
How did RTSL perform over the long term?
See historical performance and comparison